Much anticipated Phase 3 data for Alzheimer’s drug lecanemab was presented at CTAD, showing the drug is as safe as the placebo with improvements…
While there is a lack of evidence supporting the use of natural supplements for Alzheimer’s disease, experts share best practices for those who are still…
This Giving Tuesday, consider donating to help fund Alzheimer’s and dementia research. More than 6.5 million Americans are living with Alzheimer’s. By 2050, this…
Actor Chris Hemsworth, 39, recently discovered that he has a genetic risk factor for Alzheimer’s. Here’s a closer look at the gene in question. …
They’ve been studying the same group of people for 76 years. This is what they’ve learned about Alzheimer’s disease… so far. Psychology in epidemiology…
In Phase 3 trials, Roche’s experimental Alzheimer’s drug gantenerumab has failed to meet its objectives for slowing cognitive decline. Most Alzheimer’s treatments on the market…
A class of medications called cholinesterase inhibitors help to turn back the clock on Alzheimer’s disease’s cognitive symptoms. More than a third people over…